Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hay

Showing results (501-510 of 515) with videos related to

Pageof 52
Sort By:
American Journal of Obstetrics and Gynecology|December 30, 2021
The importance of nutrition in pregnancy and lactation: lifelong consequencesNicole E Marshall, Barbara Abrams, Linda A Barbour, et al.
Farmaco (Societa Chimica Italiana : 1989)|August 12, 1999
Replacement of the quinoline system in 2-phenyl-4-quinolinecarboxamide NK-3 receptor antagonistsG A Giardina, M Artico, S Cavagnera, et al.
Journal of Medicinal Chemistry|May 18, 2001
Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity and selectivity in quinoline tachykinin receptor antagonistsF E Blaney, L F Raveglia, M Artico, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|March 28, 2020
"Extrauterine growth restriction" and "postnatal growth failure" are misnomers for preterm infantsTanis R Fenton, Barbara Cormack, Dena Goldberg, et al.
American Journal of Obstetrics and Gynecology|July 1, 2018
A cautionary response to SMFM statement: pharmacological treatment of gestational diabetesLinda A Barbour, Christina Scifres, Amy M Valent, et al.
The Journal of Spinal Cord Medicine|April 18, 2017
Lifestyle intervention for adults with spinal cord injury: Results of the USC-RLANRC Pressure Ulcer Prevention StudyMike Carlson, Cheryl L P Vigen, Salah Rubayi, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2000
Nonpeptide tachykinin receptor antagonists. II. Pharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potent and selective NK-3 receptor antagonistH M Sarau, D E Griswold, B Bush, et al.
British Journal of Anaesthesia|June 13, 2013
Combined dysfunctions of immune cells predict nosocomial infection in critically ill patientsA Conway Morris, N Anderson, M Brittan, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|September 7, 1999
In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activityH M Sarau, J J Foley, D B Schmidt, et al.
Blood|February 5, 2011
C5a-mediated neutrophil dysfunction is RhoA-dependent and predicts infection in critically ill patientsAndrew Conway Morris, Mairi Brittan, Thomas S Wilkinson, et al.
Pageof 52

Showing results (501-510 of 515) with videos related to

Sort By:
Pageof 52
American Journal of Obstetrics and Gynecology|December 30, 2021
The importance of nutrition in pregnancy and lactation: lifelong consequencesNicole E Marshall, Barbara Abrams, Linda A Barbour, et al.
Farmaco (Societa Chimica Italiana : 1989)|August 12, 1999
Replacement of the quinoline system in 2-phenyl-4-quinolinecarboxamide NK-3 receptor antagonistsG A Giardina, M Artico, S Cavagnera, et al.
Journal of Medicinal Chemistry|May 18, 2001
Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity and selectivity in quinoline tachykinin receptor antagonistsF E Blaney, L F Raveglia, M Artico, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|March 28, 2020
"Extrauterine growth restriction" and "postnatal growth failure" are misnomers for preterm infantsTanis R Fenton, Barbara Cormack, Dena Goldberg, et al.
American Journal of Obstetrics and Gynecology|July 1, 2018
A cautionary response to SMFM statement: pharmacological treatment of gestational diabetesLinda A Barbour, Christina Scifres, Amy M Valent, et al.
The Journal of Spinal Cord Medicine|April 18, 2017
Lifestyle intervention for adults with spinal cord injury: Results of the USC-RLANRC Pressure Ulcer Prevention StudyMike Carlson, Cheryl L P Vigen, Salah Rubayi, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2000
Nonpeptide tachykinin receptor antagonists. II. Pharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potent and selective NK-3 receptor antagonistH M Sarau, D E Griswold, B Bush, et al.
British Journal of Anaesthesia|June 13, 2013
Combined dysfunctions of immune cells predict nosocomial infection in critically ill patientsA Conway Morris, N Anderson, M Brittan, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|September 7, 1999
In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activityH M Sarau, J J Foley, D B Schmidt, et al.
Blood|February 5, 2011
C5a-mediated neutrophil dysfunction is RhoA-dependent and predicts infection in critically ill patientsAndrew Conway Morris, Mairi Brittan, Thomas S Wilkinson, et al.
Pageof 52